Literature DB >> 33800490

The Role of Chronic Inflammation in Polycystic Ovarian Syndrome-A Systematic Review and Meta-Analysis.

Shaimaa Aboeldalyl1,2, Cathryn James3, Emaduldin Seyam2, Emad Moussa Ibrahim2, Hossam El-Din Shawki2, Saad Amer1.   

Abstract

Although the current literature associates polycystic ovarian syndrome (PCOS) with chronic inflammation, the evidence for this link remains inconclusive and its causal nature remains unclear. The purpose of this systematic review was to assess the inflammatory status in PCOS women and to determine whether it is related to PCOS or to its associated adiposity. We searched electronic databases including PUBMED, EMBASE and MEDLINE, SCOPUS, DynaMed plus, TRIP, ScienceDirect and Cochrane Library, for studies investigating C-reactive protein (CRP) and other inflammatory makers in PCOS women versus healthy controls. Quality and risk of bias for selected studies were assessed using the modified Newcastle-Ottawa scale. CRP data were extracted and pooled using RevMan for calculation of the standardized mean difference (SMD) and 95% confidence interval (CI). Eighty-five eligible studies were included in the systematic review, of which 63 were included in the meta-analysis. Pooled analysis of the 63 studies revealed significantly higher circulating CRP in PCOS women (n = 4086) versus controls (n = 3120) (SMD 1.26, 95%CI, 0.99, 1.53). Sensitivity meta-analysis of 35 high quality studies including non-obese women showed significantly higher circulating CRP in PCOS women versus controls (SMD 1.80, 95%CI, 1.36, 2.25). In conclusion, circulating CRP is moderately elevated in PCOS women independent of obesity, which is indicative of low-grade chronic inflammation.

Entities:  

Keywords:  C-reactive protein; chronic inflammation; inflammatory markers; insulin resistance; obesity; polycystic ovarian syndrome

Mesh:

Substances:

Year:  2021        PMID: 33800490      PMCID: PMC7962967          DOI: 10.3390/ijms22052734

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  142 in total

1.  The expression of sex steroid synthesis and inactivation enzymes in subcutaneous adipose tissue of PCOS patients.

Authors:  Lihua Wang; Shengxian Li; Aimin Zhao; Tao Tao; Xiuying Mao; Ping Zhang; Wei Liu
Journal:  J Steroid Biochem Mol Biol       Date:  2012-02-21       Impact factor: 4.292

2.  Bisphenol A in polycystic ovary syndrome and its association with liver-spleen axis.

Authors:  Giovanni Tarantino; Rossella Valentino; Carolina Di Somma; Vittoria D'Esposito; Federica Passaretti; Genoveffa Pizza; Valentina Brancato; Francesco Orio; Pietro Formisano; Annamaria Colao; Silvia Savastano
Journal:  Clin Endocrinol (Oxf)       Date:  2013-03       Impact factor: 3.478

Review 3.  The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity.

Authors:  Brent E Wisse
Journal:  J Am Soc Nephrol       Date:  2004-11       Impact factor: 10.121

4.  Women with polycystic ovary syndrome have increased plasma chitotriosidase activity: a pathophysiological link between inflammation and impaired insulin sensitivity?

Authors:  A Aydogdu; I Tasci; S Tapan; A Sonmez; U Aydogan; H Akbulut; G Uckaya; S Aydogdu; Y Basaran; C Meric; A Taslipinar; I Kurt; O Azal
Journal:  Exp Clin Endocrinol Diabetes       Date:  2012-04-27       Impact factor: 2.949

Review 5.  Inflammation in Polycystic Ovary Syndrome: underpinning of insulin resistance and ovarian dysfunction.

Authors:  Frank González
Journal:  Steroids       Date:  2011-12-08       Impact factor: 2.668

6.  Study on chronic low-grade inflammation and influential factors of polycystic ovary syndrome.

Authors:  Xiangyan Ruan; Yujie Dai
Journal:  Med Princ Pract       Date:  2009-02-09       Impact factor: 1.927

7.  Circulating levels of C1q/TNF-α-related protein 6 (CTRP6) in polycystic ovary syndrome.

Authors:  Asie Sadeghi; Reza Fadaei; Nariman Moradi; Fatima Z Fouani; Maryam Roozbehkia; Zahra Zandieh; Soheila Ansaripour; Akram Vatannejad; Amir H Doustimotlagh
Journal:  IUBMB Life       Date:  2020-03-14       Impact factor: 3.885

8.  The effect of bariatric surgery on inflammatory markers in women with polycystic ovarian syndrome.

Authors:  Firass Abiad; Dalia Khalife; Bassem Safadi; Ramzi Alami; Johnny Awwad; Fatin Khalifeh; Ghina Ghazeeri
Journal:  Diabetes Metab Syndr       Date:  2018-06-22

9.  Metformin treatment may increase omentin-1 levels in women with polycystic ovary syndrome.

Authors:  Bee K Tan; Raghu Adya; Syed Farhatullah; Jing Chen; Hendrik Lehnert; Harpal S Randeva
Journal:  Diabetes       Date:  2010-09-17       Impact factor: 9.461

10.  Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.

Authors:  Nervana Samy; Maha Hashim; Magda Sayed; Mohamed Said
Journal:  Dis Markers       Date:  2009       Impact factor: 3.434

View more
  10 in total

1.  Quantitative Changes in White Blood Cells: Correlation with the Hallmarks of Polycystic Ovary Syndrome.

Authors:  Abdulrahman H Almaeen; Abdulrahman Abdulwahab Alduraywish; Mudasar Nabi; Naveed Nazir Shah; Rahiman Shaik; Bilal Ahmad Tantry
Journal:  Medicina (Kaunas)       Date:  2022-04-12       Impact factor: 2.948

2.  Metabolically Healthy Obesity (MHO) vs. Metabolically Unhealthy Obesity (MUO) Phenotypes in PCOS: Association with Endocrine-Metabolic Profile, Adherence to the Mediterranean Diet, and Body Composition.

Authors:  Luigi Barrea; Giovanna Muscogiuri; Gabriella Pugliese; Giulia de Alteriis; Annamaria Colao; Silvia Savastano
Journal:  Nutrients       Date:  2021-11-02       Impact factor: 5.717

3.  Molecular docking and mouse modeling suggest CMKLR1 and INSR as targets for improving PCOS phenotypes by minocycline.

Authors:  Mahdie Kian; Elham Hosseini; Tooba Abdizadeh; Taimour Langaee; Azadeh Khajouei; Sorayya Ghasemi
Journal:  EXCLI J       Date:  2022-02-16       Impact factor: 4.068

Review 4.  Controversies in the Pathogenesis, Diagnosis and Treatment of PCOS: Focus on Insulin Resistance, Inflammation, and Hyperandrogenism.

Authors:  Decio Armanini; Marco Boscaro; Luciana Bordin; Chiara Sabbadin
Journal:  Int J Mol Sci       Date:  2022-04-08       Impact factor: 6.208

5.  Response to Letter to the Editor From Jialal: "Higher Incidence of Metabolic Syndrome in Black Women With Polycystic Ovary Disease: A Longitudinal Study".

Authors:  Iris Lee; Anuja Dokras
Journal:  J Clin Endocrinol Metab       Date:  2022-04-19       Impact factor: 5.958

Review 6.  Royal Jelly as a Nutraceutical Natural Product with a Focus on Its Antibacterial Activity.

Authors:  Lilla Bagameri; Gabriela-Maria Baci; Daniel Severus Dezmirean
Journal:  Pharmaceutics       Date:  2022-05-27       Impact factor: 6.525

7.  The Effect of Age on IVF-ET Outcome in Infertile Patients with PCOS Based on Tiangui Theory in Chinese Medicine.

Authors:  Hui Chang; Jian Li; Qi Wu; Xin Fu; Mengyi Zhu; Hang Ge; Baichao Shi; Xiaoguang Shao; Yanhua Han
Journal:  Evid Based Complement Alternat Med       Date:  2022-08-22       Impact factor: 2.650

8.  Inflammatory Markers in Non-Obese Women with Polycystic Ovary Syndrome Are Not Elevated and Show No Correlation with Vitamin D Metabolites.

Authors:  Abu Saleh Md Moin; Thozhukat Sathyapalan; Stephen L Atkin; Alexandra E Butler
Journal:  Nutrients       Date:  2022-08-27       Impact factor: 6.706

9.  Association between neutrophil-to-lymphocyte ratio and polycystic ovary syndrome: A PRISMA-compliant systematic review and meta-analysis.

Authors:  Li Li; Jianxiu Yu; Zhongwei Zhou
Journal:  Medicine (Baltimore)       Date:  2022-09-23       Impact factor: 1.817

Review 10.  Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility.

Authors:  Valeria Calcaterra; Elvira Verduci; Hellas Cena; Vittoria Carlotta Magenes; Carolina Federica Todisco; Elisavietta Tenuta; Cristina Gregorio; Rachele De Giuseppe; Alessandra Bosetti; Elisabetta Di Profio; Gianvincenzo Zuccotti
Journal:  Nutrients       Date:  2021-05-28       Impact factor: 5.717

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.